These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 25339672

  • 1. Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment.
    Wehrli M, Cortinas-Elizondo F, Hlushchuk R, Daudel F, Villiger PM, Miescher S, Zuercher AW, Djonov V, Simon HU, von Gunten S.
    J Immunol; 2014 Dec 01; 193(11):5649-59. PubMed ID: 25339672
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S, Rossato E, Heming N, Monteiro RC.
    Autoimmun Rev; 2013 Apr 01; 12(6):666-9. PubMed ID: 23201915
    [Abstract] [Full Text] [Related]

  • 3. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
    Heineke MH, van der Steen LPE, Korthouwer RM, Hage JJ, Langedijk JPM, Benschop JJ, Bakema JE, Slootstra JW, van Egmond M.
    Eur J Immunol; 2017 Oct 01; 47(10):1835-1845. PubMed ID: 28736835
    [Abstract] [Full Text] [Related]

  • 4. Targeting FcαRI on polymorphonuclear cells induces tumor cell killing through autophagy.
    Bakema JE, Ganzevles SH, Fluitsma DM, Schilham MW, Beelen RH, Valerius T, Lohse S, Glennie MJ, Medema JP, van Egmond M.
    J Immunol; 2011 Jul 15; 187(2):726-32. PubMed ID: 21653835
    [Abstract] [Full Text] [Related]

  • 5. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E, Heineke MH, van Egmond M.
    Immunol Rev; 2015 Nov 15; 268(1):123-38. PubMed ID: 26497517
    [Abstract] [Full Text] [Related]

  • 6. Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis.
    Watanabe T, Kanamaru Y, Liu C, Suzuki Y, Tada N, Okumura K, Horikoshi S, Tomino Y.
    Clin Exp Immunol; 2011 Nov 15; 166(2):235-50. PubMed ID: 21985370
    [Abstract] [Full Text] [Related]

  • 7. Crosslinking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89.
    van Zandbergen G, Westerhuis R, Mohamad NK, van De Winkel JG, Daha MR, van Kooten C.
    J Immunol; 1999 Dec 01; 163(11):5806-12. PubMed ID: 10570263
    [Abstract] [Full Text] [Related]

  • 8. IgA Fc receptors.
    Monteiro RC, Van De Winkel JG.
    Annu Rev Immunol; 2003 Dec 01; 21():177-204. PubMed ID: 12524384
    [Abstract] [Full Text] [Related]

  • 9. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
    Valerius T, Stockmeyer B, van Spriel AB, Graziano RF, van den Herik-Oudijk IE, Repp R, Deo YM, Lund J, Kalden JR, Gramatzki M, van de Winkel JG.
    Blood; 1997 Dec 01; 90(11):4485-92. PubMed ID: 9373259
    [Abstract] [Full Text] [Related]

  • 10. IgA Complexes in Plasma and Synovial Fluid of Patients with Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via FcαRI.
    Aleyd E, Al M, Tuk CW, van der Laken CJ, van Egmond M.
    J Immunol; 2016 Dec 15; 197(12):4552-4559. PubMed ID: 27913645
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin A: magic bullet or Trojan horse?
    Heineke MH, van Egmond M.
    Eur J Clin Invest; 2017 Feb 15; 47(2):184-192. PubMed ID: 28024097
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89).
    van Egmond M, van Spriel AB, Vermeulen H, Huls G, van Garderen E, van de Winkel JG.
    Cancer Res; 2001 May 15; 61(10):4055-60. PubMed ID: 11358825
    [Abstract] [Full Text] [Related]

  • 13. Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor.
    Kanamaru Y, Arcos-Fajardo M, Moura IC, Tsuge T, Cohen H, Essig M, Vrtovsnik F, Loirat C, Peuchmaur M, Beaudoin L, Launay P, Lehuen A, Blank U, Monteiro RC.
    Eur J Immunol; 2007 Apr 15; 37(4):1116-28. PubMed ID: 17393381
    [Abstract] [Full Text] [Related]

  • 14. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcalphaRI (CD89).
    van der Pol W, Vidarsson G, Vilé HA, van de Winkel JG, Rodriguez ME.
    J Infect Dis; 2000 Oct 15; 182(4):1139-45. PubMed ID: 10979910
    [Abstract] [Full Text] [Related]

  • 15. Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein.
    Lu J, Marjon KD, Marnell LL, Wang R, Mold C, Du Clos TW, Sun P.
    Proc Natl Acad Sci U S A; 2011 Mar 22; 108(12):4974-9. PubMed ID: 21383176
    [Abstract] [Full Text] [Related]

  • 16. Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells.
    Pasquier B, Lepelletier Y, Baude C, Hermine O, Monteiro RC.
    J Leukoc Biol; 2004 Dec 22; 76(6):1134-41. PubMed ID: 15371488
    [Abstract] [Full Text] [Related]

  • 17. FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.
    Wu J, Ji C, Xie F, Langefeld CD, Qian K, Gibson AW, Edberg JC, Kimberly RP.
    J Immunol; 2007 Mar 15; 178(6):3973-82. PubMed ID: 17339498
    [Abstract] [Full Text] [Related]

  • 18. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA, van Egmond M.
    Immunol Lett; 2004 Mar 29; 92(1-2):23-31. PubMed ID: 15081523
    [Abstract] [Full Text] [Related]

  • 19. Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.
    Bakema JE, de Haij S, den Hartog-Jager CF, Bakker J, Vidarsson G, van Egmond M, van de Winkel JG, Leusen JH.
    J Immunol; 2006 Mar 15; 176(6):3603-10. PubMed ID: 16517729
    [Abstract] [Full Text] [Related]

  • 20. Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells.
    Otten MA, Bakema JE, Tuk CW, Glennie MJ, Tutt AL, Beelen RH, van de Winkel JG, van Egmond M.
    Eur J Immunol; 2012 Jul 15; 42(7):1815-21. PubMed ID: 22535639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.